ANI Pharmaceuticals (ANIP) P/E US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/E | ? | 119.8 | -15.4 | -13.6 | -13.7 | 52.9 | 44.7 | ||
Changes by years, y/y, % | +250% | -113% | -12% | +0% | -487% | +9.1% |
ANI Pharmaceuticals. P/E
ANI Pharmaceuticals. P/E, changes, %
ANI Pharmaceuticals (ANIP) P/E US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
P/E | ? | -184.6 | 81.9 | 55.8 | 37.1 | 45.5 | 44.7 | |
Changes by years, y/y, % | +3 361% | -1 581% | -507% | -250% | -125% | |||
Changes by quarters, q/q, % | +646% | -144% | -32% | -33% | +23% |